Atara Biotherapeutics Reports that the Resubmitted Tabelecleucel (Tab-cel®) Biologics License Application Has Been Accepted by the U.S. Food and Drug Administration
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
| (NASDAQ: ATRA) | Delayed: 9.35 +0.19 (2.07%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.16 | 52 Week High | $40.80 | |||
| Open | $9.25 | 52 Week Low | $12.45 | |||
| Day High | $9.43 | P/E | N/A | |||
| Day Low | $9.17 | EPS | $0.00 | |||
| Volume | 26,545 | |||||
